Purchases and Sales Made in Q2 2024 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q2 2024. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
49.9K+ 12.58% |
$57.9K - $76.4K
|
447K
$335K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
24.7KNew |
$28.6K - $37.7K
|
24.7K
$18.5K
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
BUY
|
- |
22.4K+ 60.29% |
$26K - $34.2K
|
59.5K
$44.6K
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
15.7K+ 9.81% |
$18.2K - $24K
|
175K
$132K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
BUY
|
- |
7.23K+ 149.65% |
$8.38K - $11.1K
|
12.1K
$9.04K
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
183+ 677.78% |
$212 - $280
|
210
$158
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6- 0.58% |
$6.96 - $9.18
|
1.03K
$773
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6- 0.58% |
$6.96 - $9.18
|
1.03K
$773
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-19- 0.09% |
$22 - $29.1
|
21.7K
$16.3K
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-174- 3.81% |
$202 - $266
|
4.39K
$3.29K
|
|
Aug 13, 2024
Q2 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.58K- 24.05% |
$1.84K - $2.42K
|
5K
$3.75K
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-8.4K- 38.61% |
$9.74K - $12.9K
|
13.4K
$10K
|
|
Aug 09, 2024
Q2 2024
|
Epiq Capital Group, LLC
San Francisco, CA |
SELL
|
- |
-36.5K- 4.28% |
$42.4K - $55.9K
|
817K
$613K
|